The Rosenman Institute, a medical technology partnership between California Institute for Quantitative Bioscience (QB3), the UCSF Department of Surgery, the UCSF Department of Bioengineering and Therapeutic Sciences (BTS), and Friends of Dan Rosenman, was conceived and started development last fall. It will be launching a symposium this Wednesday, June 4th with the purpose of introducing the Rosenman Institute to the Bay Area medical device community and raising awareness among surgeons/clinicians and bioengineers of what the Rosenman Institute can do for them. There will be a panel discussion with the Rosenman Fellows to better understand the breadth of experience the Rosenman Fellows offer that can help bring your ideas to commercialization. The other event speakers include experts on innovation, entrepreneurship, and finance in the medical device field.

We took the chance to interview Christine Winoto (QB3 Assistant Director) to learn more about the plans for the Institute.

Read the interview at Medgadget